Have you or a loved one taken Aduhelm to manage Alzheimer's symptoms?

Aduhelm™ (aducanumab), a drug used to treat Alzheimer’s disease, was approved by the US Food and Drug Administration (FDA) in June 2021. In February 2024 Biogen announced that they would be discontinuing it by the end of 2024.

If you or a loved one had taken Aduhelm, we'd love to know what your experience with it was/has been.

For those interested, you can read more about the drug here: https://alzheimersdisease.net/news/aduhelm-aducanumab-updates